Physician profile
Benjamin William Hunter
NPI 1477181873
$899.71
in general payments reported to CMS, 2019-2025
10 companies · $14.78 in 2025
The $14.78 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $101 · 2023: $352 · 2024: $432 · 2025: $14.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $798.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $388.17 | 2023-2025 | Farxiga, Breztri, Airsupra |
| Axsome Therapeutics, INC. | $114.30 | 2023-2024 | Sunosi |
| Exact Sciences Corporation | $104.29 | 2023-2024 | Cologuard Collection Kit |
| Mannkind Corporation | $77.94 | 2022 | |
| Abbvie INC. | $63.14 | 2023-2024 | |
| Novo Nordisk INC | $57.92 | 2023-2024 | Rybelsus, Ozempic |
| Lilly USA, LLC | $30.39 | 2023-2024 | Jardiance, Zepbound, Mounjaro |
| Abbott Laboratories | $23.44 | 2023 | Optis |
| Organon LLC | $23.26 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.86 | 2024 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.